Exicure GAAP EPS -$0.79 Raises Investor Scrutiny Exicure reported GAAP EPS of -$0.79 on Mar 26, 2026 (Seeking Alpha); investors should verify cash runway and EPS drivers to assess dilution and trial-risk.

Exicure GAAP EPS -$0.79 Raises Investor Scrutiny: Exicure reported GAAP EPS of -$0.79 on Mar 26, 2026 (Seeking Alpha); investors should verify cash runway and EPS drivers to assess dilution and trial-risk. 👈 Read full analysis #Exicure #Finance #Investing #EPS #Biotech

Is #XCUR worth buying? #exicure #stocks #growthshares